Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “European Commission”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 37 records · Page 2Linked to original sources

European School of Oncology Advisory report to the European Commission for the "Europe Against Cancer Programme" European Code Against Cancer.

A European School of Oncology Advisory Group has reviewed the European Code Against Cancer after its initial use over a 6-year period. With minor modifications, the original ten recommendations were found to be adequate, although it was agreed that an Annex was necessary to explain the scientific evidence supporting each point, and is presented herewith. Tobacco smoking clearly remains the most important cause of cancer, and now it can be quantified better than ever before. It is also clear that it is never too late to stop smoking: stopping even in middle age, prior to the onset of serious illness has a beneficial effect on life expectancy. Alcohol drinking is an important cause of cancer, and yet modest consumption levels protect against cardiovascular disease mortality. The optimal strategy seems to be a consumption not exceeding 2-3 drinks per day, although this limit may be lower for women. Increased consumption of fruits and vegetables, reduction in consumption of fatty foods, reduction of obesity and increased physical activity can all be recommended to reduce cancer risk. Exposure to excessive sunlight remains a problem which should be limited. Control of occupational cancer is a three-way partnership: legislation identifies and limits exposure to known carcinogens, employers enact the legislation and workers should respect the measures introduced. There are a number of signs and symptoms which may lead to cancer being diagnosed earlier, and patients with these should be referred to a doctor. For women, participation in organised programmes of cervical cancer and breast cancer (after 50 years of age) should lead to a reduction in mortality from these forms of cancer. The key element is organised programmes, where quality control and quality assurance are in force. These revised recommendations are the result of an agreement following advice, review and dialogue with cancer experts throughout Europe. They were approved by the European Community Cancer Experts at their meeting in Bonn on 28-29 November 1994. Their implementation by the European population should greatly reduce cancer incidence and mortality.

Alcohol Drinking↗

Application of European Commission reference dose levels in CT examinations in Crete, Greece.

The purpose of this study was to apply European Commission reference dose levels (EC RDLs) to routine CT examinations. The dosimetric quantities proposed in the European Guidelines (EG) for CT are weighted computed tomography dose index (CTDI(w)) for a single slice and dose-length product (DLP) for a complete examination. Patient-related data as well as technical parameters for brain, chest, abdomen and pelvis examinations were collected for four CT scanners in the Euromedica Medical Center. Computed tomography dose index (CTDI) measurements were performed on each scanner and CTDI(w), DLP and effective dose E were estimated for each type of examination for a random sample of 10 typical patients. Mean values of CTDI(w) had a range of 27.0-52.0 mGy for brain and 13.9-26.9 mGy for chest, abdomen and pelvis examinations. Mean values of DLP had a range of 430-758 mGy cm for brain, 348-807 mGy cm for chest, 278-582 mGy cm for abdomen and 306-592 mGy cm for pelvis examinations. Mean values of E were 1.4 mSv for brain, 10.9 mSv for chest, 7.1 mSv for abdomen and 9.3 mSv for pelvis examinations. Results confirm that the Euromedica Medical Center meets EC RDLs for brain, abdomen and pelvis examinations, in terms of radiation dose and examination technique. As far as chest examination is concerned, although CTDI(w) of each scanner is within proposed values, the DLP is consistently exceeded, probably because of the large irradiation volume length L. It is anticipated that a reduction of L, or product mAs, or their combination, will reduce DLP without affecting image quality.

Brain↗

Cost-utility analysis of assistive technologies in the European Commission's TIDE Program. Technology Initiative for Disabled and Elderly People.

Socioeconomic evaluation is an issue dealt with in the European Commission's research program TIDE. The principles of cost-utility analysis have been examined for usability in the assessment of rehabilitative technologies. A case study, the choice of a type of wheelchair, is described to demonstrate how estimates of utility can be derived and how cost-utility ratios can be used to guide decision making.

Aged↗

Increasing the impact of European obesity research in preparation for the European research area: a report on the 2003 European Commission Obesity Workshop.

Leading obesity researchers from across Europe assembled in Aberdeen, Scotland, in January 2003 to consider how to increase the impact of European obesity research. The workshop was funded by the European Commission and hosted by the Rowett Research Institute, Aberdeen. The delegates identified the need to (i) develop a portfolio of studies that integrate genetics and mechanisms through parallel study of humans and animal models and (ii) establish major intervention studies in weight management and early life nutrition. It was recommended that these goals would be best achieved under the umbrella of a virtual European Obesity Research Institute, or Network of Excellence in Obesity Research under Framework Programme 6, that would facilitate harmonization of methodology, manage centralized standardized resources, coordinate training initiatives, workshops and working groups, and increase focus.

Diet↗

NoiseChem: an European Commission research project on the effects of exposure to noise and industrial chemicals on hearing and balance.

Exposure to multiple physical and chemical agents is common in occupational environments but workplace hazards and occupational safety criteria for combined exposures are lacking. NoiseChem is an European Commission research project examining the effects of exposure to noise and chemicals on hearing and balance. Partners in Sweden, Finland, France, Denmark, UK and Poland with expert guidance from partners in the USA will examine workers and study the mechanisms of action in animals to determine the levels of risk associated with joint exposure to noise and solvents. This paper briefly outlines the project details.

Animals↗

NoiseChem: An European Commission research project on the effects of exposure to noise and industrial chemicals on hearing and balance.

Exposure to multiple physical and chemical agents is common in occupational environments but workplace hazards and occupational safety criteria for combined exposures is lacking. NoiseChem is an European Commission research project examining the effects of exposure to noise and chemicals on hearing and balance. Partners in Sweden, Finland, France, Denmark, UK and Poland with expert guidance from partners in USA will examine workers and study the mechanisms of action in animals to determine the levels of risk associated with joint exposure to noise and solvents. This paper briefly outlines the project details.

Journal Article↗

Critical outlook and trends for environmental reference materials at the Measurements & Testing Generic Activity (European Commission).

It is now well recognised that the quality control (QC) of all types of analyses, including environmental analyses depends on the appropriate use of reference materials. One of the ways to check the accuracy of methods is based on the use of Certified Reference Materials (CRMs), whereas other types of (not certified) Reference Materials (RMs) are used for routine quality control (establishment of control charts) and interlaboratory testing (e.g. proficiency testing). The perception of these materials, in particular with respect to their production and use, differs widely according to various perspectives (e.g. RM producers, routine laboratories, researchers). This review discusses some critical aspects of RM use and production for the QC of environmental analyses and describes the new approach followed by the Measurements & Testing Generic Activity (European Commission) to tackle new research and production needs.

Environmental Monitoring↗

Patients' understanding of risk associated with medication use: impact of European Commission guidelines and other risk scales.

Patients want and need comprehensive and accurate information about their medicines so that they can participate in decisions about their healthcare. In particular, they require information about the likely risks and benefits that are associated with the different treatment options. However, to provide this information in a form that people can readily understand and use is a considerable challenge to healthcare professionals. One recent attempt to standardise the language of risk has been to produce sets of verbal descriptors that correspond to specific probability ranges, such as those outlined in the European Commission (EC) Pharmaceutical Committee guidelines in 1998 for describing the incidence of adverse effects. This paper provides an overview of a number of studies involving members of the general public, patients, and hospital doctors, that evaluated the utility of the EC guideline descriptors (very common, common, uncommon, rare, very rare). In all studies it was found that people significantly over-estimated the likelihood of adverse effects occurring, given specific verbal descriptors. This in turn resulted in significantly higher ratings of their perceived risks to health and significantly lower ratings of their likelihood of taking the medicine. Such problems of interpretation are not restricted to the EC guideline descriptors. Similar levels of misinterpretation have also been demonstrated with two other recently advocated risk scales (Calman's verbal descriptor scale and Barclay, Costigan and Davies' lottery scale). In conclusion, the challenge for risk communicators and for future research will be to produce a language of risk that is sufficiently flexible to take into account different perspectives, as well as changing circumstances and contexts of illness and its treatments. In the meantime, we urge the EC and other legislative bodies to stop recommending the use of specific verbal labels or phrases until there is a stronger evidence base to support their use.

Communication↗

Proposals for European Commission guidelines in the use of ambulatory blood pressure monitoring to evaluate antihypertensive drugs.

Different national authorities have different requirements before antihypertensive drugs can be approved for clinical use. Traditionally, antihypertensive treatment is evaluated by blood pressure measurements made by standardized casual readings. Twenty-four-hour ambulatory blood pressure monitoring provides additional information on the antihypertensive profile of a drug. In antihypertensive drug studies, this technique reduces the sample size required, has no placebo effect and provides more detailed information on first-dose effects, the duration of action and dose-response relationships. Accordingly, proposals are being made that might form the basis of European Commission (EC) guidelines for ambulatory blood pressure monitoring, thus standardizing the present different national requirements.

Antihypertensive Agents↗

Application of draft European Commission reference levels to a regional CT dose survey.

A survey of CT doses in Northern Ireland in the period between October 1995 and March 1997 was carried out. The survey included all but one of the 10 scanners in use at the time, and, additionally, two others that were replacement machines. The method used was to study standard protocols and calculate doses to the NRPB mathematical phantom, so that a direct comparison could be made with other surveys carried out in a similar fashion elsewhere. The survey addressed the patient radiation dose but not image quality or clinical outcomes. It is estimated that in Northern Ireland the contribution to collective dose to the population from CT is about 40% of that from all medical X-rays. The proposed European Commission reference quantities, weighted CT dose index and dose-length product were computed and their potential use evaluated. A full study of mean values of effective dose per examination revealed the average dose per examination was not significantly different from that found in the 1989 UK survey, although several procedures gave rise to doses that were high enough to be investigated with a view to justification or reduction. One of the scanners was found to give consistently high doses. It is likely that a revision of the mAs values used on this scanner will produce a significant reduction in patient doses without compromising image quality. When compared with the draft EC reference levels, fewer procedures were found to have excessively high dose values. The proposed EC reference levels would therefore be useful for continual monitoring of CT dose status, but do not appear to provide as comprehensive an assessment of patient exposure as that given by consideration of effective doses.

Clinical Protocols↗